Company / Current Assets per Share
Perspective Therapeutics, Inc. Current Assets per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.37
FY2022
5-year range
$0.08 / $0.98
FY2018-FY2022
Trend
-61.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 10 years, ranging from $0.08 in FY2020 to $0.98 in FY2021.
Based on SEC 10-K filings.
0.37 in FY2022 with a 5-year CAGR of +14.9%.
Improved from $0.08 to $0.37 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +42.4%
- 5-Year CAGR
- +14.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current assets per share decreased 61.6% year-over-year.
- Peak current assets per share was recorded in FY2021.
- Lowest current assets per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.37 | -61.6% |
| FY2021 | $0.98 | +1095.3% |
| FY2020 | $0.08 | -37.1% |
| FY2019 | $0.13 | +31.2% |
| FY2018 | $0.10 | -47.1% |
| FY2017 | $0.19 | -43.0% |
| FY2016 | $0.33 | -16.5% |
| FY2015 | $0.39 | -29.2% |
| FY2014 | $0.56 | +286.6% |
| FY2013 | $0.14 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026